<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-pharmaceutics-11-00021" class="ref">
 <label class="label">41.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Abuzar</surname>
    <given-names class="given-names">S.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hyun</surname>
    <given-names class="given-names">S.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kim</surname>
    <given-names class="given-names">J.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Park</surname>
    <given-names class="given-names">H.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kim</surname>
    <given-names class="given-names">M.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Park</surname>
    <given-names class="given-names">J.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hwang</surname>
    <given-names class="given-names">S.J.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process</article-title>
  <source class="source">Int. J. Pharm.</source>
  <year class="year">2018</year>
  <volume class="volume">538</volume>
  <fpage class="fpage">1</fpage>
  <lpage class="lpage">13</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.ijpharm.2017.12.041</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">29278733</pub-id>
 </element-citation>
</ref>
